Search hospitals > Maryland > Towson
UM Saint Joseph Medical Center
Claim this profileTowson, Maryland 21204
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Coronary Artery Disease
Conducts research for Myocardial Ischemia
Conducts research for Lung Cancer
55 reported clinical trials
5 medical researchers
Summary
UM Saint Joseph Medical Center is a medical facility located in Towson, Maryland. This center is recognized for care of Breast Cancer, Cancer, Coronary Artery Disease, Myocardial Ischemia, Lung Cancer and other specialties. UM Saint Joseph Medical Center is involved with conducting 55 clinical trials across 113 conditions. There are 5 research doctors associated with this hospital, such as Kimberly W. Schlesinger, Richard M. Schraeder, Selvi Lingam, and Stephen K. Ronson.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Kimberly W. SchlesingerUM Saint Joseph Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
3 reported clinical trials
7 drugs studied
Richard M. SchraederUM Saint Joseph Medical Center2 years of reported clinical research
Studies Blood Cancers
Studies Tumors
2 reported clinical trials
7 drugs studied
Selvi LingamUM Saint Joseph Medical Center3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
2 reported clinical trials
6 drugs studied
Stephen K. RonsonUM Saint Joseph Medical Center3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
2 reported clinical trials
5 drugs studied
Clinical Trials running at UM Saint Joseph Medical Center
Breast Cancer
Pancreatic Cancer
Cancer
Adenosquamous Carcinoma
Pancreatic Carcinoma
Blood Cancers
Tumors
Anorexia
Idiopathic Pulmonary Fibrosis
Fibrosis
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UM Saint Joseph Medical Center?
UM Saint Joseph Medical Center is a medical facility located in Towson, Maryland. This center is recognized for care of Breast Cancer, Cancer, Coronary Artery Disease, Myocardial Ischemia, Lung Cancer and other specialties. UM Saint Joseph Medical Center is involved with conducting 55 clinical trials across 113 conditions. There are 5 research doctors associated with this hospital, such as Kimberly W. Schlesinger, Richard M. Schraeder, Selvi Lingam, and Stephen K. Ronson.